A
system and method for
pharmacy-level surveillance of all prescription behaviors using one or more
artificial intelligence (AI) agents integrated with real-time prescription records, refill timelines, prescriber data, patient histories, PDMP registries, and epidemiological signals. The
system evaluates these inputs with configurable
heuristics and
machine-learned models to detect prescription abuse,
public health risks, and equity or bias trends, including overlapping providers, dosage escalation, refill velocity, and prescriber clustering. When an anomaly is identified, a structured alert is routed to pharmacists, prescribers, or regulatory personnel through a secure, role-authenticated
communication interface. Each
system transaction and user outcome is captured by a Medical
Data Governance (MDG) layer, providing cryptographic sealing,
timestamping, and immutable ledger storage. In some embodiments, the audit log uses a
blockchain-based
distributed ledger. The system's feedback-driven, adaptive architecture enables analytic and policy modules to update automatically based on real-time outcomes,
public health signals, and usage trends.